Filtros de búsqueda

Lista de obras de

2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapy

artículo científico

30 Immunotherapy in advanced NSCLC—from the ‘tsunami’ of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT).

artículo científico publicado en 2018

5-HT3-receptor antagonists in the control of delayed-onset emesis.

artículo científico publicado en 2003

A multicenter randomized phase IIb efficacy study of Vx-001, a peptide-based cancer vaccine as maintenance treatment in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics

artículo científico publicado en 2013

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

artículo científico publicado en 2005

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

artículo científico publicado en 2017

A potential new therapeutic option for patients with advanced EGFR mutation-positive non-small cell lung cancer in first-line setting

artículo científico publicado en 2016

A “live” biopsy in a small-cell lung cancer patient by detection of circulating tumor cells

article by Simona Bevilacqua et al published July 2009 in Lung Cancer

ALK inhibitors and advanced non-small cell lung cancer (review).

artículo científico

ALK inhibitors in the treatment of advanced NSCLC.

artículo científico

ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC.

artículo científico publicado en 2013

ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance scheme.

artículo científico publicado en 2014

Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer

artículo científico publicado en 2007

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

artículo científico publicado en 2014

Advances in chemotherapy in advanced non-small-cell lung cancer

scientific article published on 12 August 2010

Agents in the preclinical development stage for non-small cell lung cancer

artículo científico publicado en 2015

Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?

artículo científico publicado en 2017

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

artículo científico publicado en 2008

An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatme

artículo científico publicado en 2008

An update on the developing mitotic inhibitors for the treatment of non-small cell carcinoma

artículo científico publicado en 2017

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

artículo científico

Anti-EGFR and antiangiogenic monoclonal antibodies in metastatic non-small-cell lung cancer

artículo científico publicado en 2016

BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer

artículo científico publicado en 2016

Biological prognostic and predictive factors in lung cancer

artículo científico publicado en 2009

Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients

artículo científico publicado en 2017

CD40 activation as potential tool in malignant neoplasms.

artículo científico publicado en 2002

Can a decisional algorithm be used in first-line treatment of advanced nonsmall cell lung cancer?

artículo científico publicado en 2010

Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study

artículo científico publicado en 2002

Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data

artículo científico publicado en 2012

Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy

artículo científico publicado en 2009

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

artículo científico publicado en 2017

Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancer

artículo científico publicado en 2009

Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?

artículo científico publicado en 2014

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

artículo científico publicado en 2003

Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence

artículo científico publicado en 2005

Chemotherapy of non-small cell lung cancer in the elderly

artículo científico publicado en 2002

Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies

artículo científico publicado en 2007

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials

artículo científico publicado en 2010

Clinico-Pathologic and Biologic Predictors of EGFR Inhibitors Activity and Efficacy in Lung and in Colorectal Cancer

Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer

artículo científico publicado en 2011

Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development

artículo científico publicado en 2008

Combined targeted therapies in non-small cell lung cancer: a winner strategy?

artículo científico publicado en 2007

Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.

artículo científico publicado en 2006

Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical case

artículo científico publicado en 2004

Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma

artículo científico publicado en 2016

Current challenges of lung cancer care in an aging population

artículo científico

Developments in pharmacotherapy for treating metastatic non-small cell lung cancer

artículo científico publicado en 2017

Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review).

artículo científico

Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?

artículo científico publicado en 2002

Does palliative chemotherapy beyond three courses benefit patients with non-small-cell lung cancer?

artículo científico publicado en 2007

Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?

artículo científico publicado en 2004

EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer

artículo científico publicado en 2017

EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population

artículo científico publicado en 2012

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial).

artículo científico publicado en 2013

Emerging drugs targeting PD-1 and PD-L1: reality or hope?

artículo científico

Emerging mitotic inhibitors for non-small cell carcinoma

artículo científico

Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer

artículo científico

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

artículo científico publicado en 2003

Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment study

artículo científico publicado en 2010

Erlotinib in non-small cell lung cancer treatment: current status and future development

artículo científico publicado en 2007

Erlotinib in non-small-cell lung cancer

artículo científico publicado en 2007

Erlotinib in the treatment of non-small cell lung cancer: current status and future developments.

artículo científico publicado en 2010

Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous no

artículo científico publicado en 2018

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

artículo científico publicado en 2007

Factors driving the choice of the best second-line treatment of advanced NSCLC.

scientific article published on January 2011

Factors influencing the choice of 5-HT3-receptor antagonist antiemetics: focus on elderly cancer patients

artículo científico publicado en 2004

Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study

artículo científico publicado en 2014

First-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer : analysis of the Italian patients enrolled in the SAiL study.

artículo científico publicado en 2012

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

artículo científico publicado en 2012

First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?

artículo científico publicado en 2011

Gefitinib as salvage therapy in pretreated patients with advanced non-small cell lung cancer. Data from a compassionate use program.

artículo científico publicado en 2004

Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical T

artículo científico publicado en 2003

Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study

artículo científico publicado en 2003

Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found?

artículo científico publicado en 2018

Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology

artículo científico publicado en 2016

Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer

artículo científico publicado en 2007

Individualized chemotherapy for elderly patients with nonsmall cell lung cancer

artículo científico publicado en 2002

International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and Hopes

artículo científico publicado en 2016

Irreversible EGFR inhibitors in the treatment of advanced NSCLC.

artículo científico publicado en 2014

Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study

artículo científico publicado en 2003

Is there a role for maintenance therapy in advanced non-small-cell lung cancer?

scientific article published on 02 March 2012

Isoflavone Extracts Enhance the Effect of Epidermal Growth Factor Receptor Inhibitors in NSCLC Cell Lines

artículo científico publicado en 2016

J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients?

artículo científico publicado en 2018

Locally advanced NCSLC in the elderly: which treatment? ⬇️

artículo científico publicado el 10 de julio de 2012

Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with pemetrexed plus cisplatin for advanced nons

artículo científico publicado en 2014

Lung cancer in the elderly

artículo científico publicado en 2007

Lung cancer resection in octogenarian patients.

artículo científico publicado en 2018

Lung cancer, elderly and immune checkpoint inhibitors.

artículo científico publicado en 2018

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r

artículo científico publicado el 16 de febrero de 2012

Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncology

artículo científico publicado en 2012

Management of unfit older patients with advanced NSCLC.

artículo científico publicado en 2009

Medical therapy of elderly patients with advanced non-small cell lung carcinoma: significance and possibilities

artículo científico publicado en 2004

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study

artículo científico publicado en 2011

Medical treatment of small cell lung cancer: state of the art and new development

artículo científico

Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC.

artículo científico publicado en 2002

Methodological aspects of lung cancer clinical trials in the era of targeted agents

artículo científico publicado en 2009

Multidisciplinary treatment of malignant pleural mesothelioma

artículo científico publicado en 2007

Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancer

artículo científico publicado en 2015

New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer

artículo científico

New avenues for second-line treatment of metastatic non-small-cell lung cancer

artículo científico publicado en 2009

New insights in drug development for the non-small cell lung cancer therapy

artículo científico publicado en 2008

New molecular targets in the treatment of NSCLC.

artículo científico

New targeted therapies and small-cell lung cancer

artículo científico publicado en 2008

Non-small cell lung cancer therapy in the elderly

artículo científico publicado el 1 de mayo de 2011

Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokinetics

artículo científico publicado en 2004

Non-small-cell lung cancer.

artículo científico publicado en 2015

Non-small-cell lung carcinoma vaccines in clinical trials

scientific article published on June 2011

Novel cytotoxic drugs in advanced nonsmall cell lung cancer

artículo científico publicado en 2016

Optimal drugs for second-line treatment of patients with small-cell lung cancer

artículo científico publicado en 2016

Oral cytotoxic drugs.

artículo científico publicado en 2002

Overcoming Resistance to EGFR Inhibitors in NSCLC.

artículo científico publicado en 2016

Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application

artículo científico publicado en 2015

PARAMOUNT: Descriptive subgroup analyses of final overall survival for the phase III study of maintenance pemetrexed versus placebo following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

artículo científico publicado en 2014

PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

artículo científico publicado en 2013

Paclitaxel plus bevacizumab for metastatic breast cancer

artículo científico publicado en 2008

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting in elderly patients

artículo científico publicado en 2005

Pancreatic involvement from heavily pretreated small cell lung cancer successfully treated with transcatheter intra-arterial chemotherapy: a case report with local and systemic disease control.

artículo científico publicado en 2002

Pattern of care for advanced non-small cell lung cancer in the era of histology-based treatment: a survey of the Italian Association of Thoracic Oncology (AIOT).

artículo científico publicado en 2009

Pemetrexed Therapy in Elderly Patients With Good Performance Status: Analysis of Two Phase III Trials of Patients With Nonsquamous Non–Small-Cell Lung Cancer ⬇️

artículo científico publicado el 23 de enero de 2012

Pemetrexed in advanced non-small cell lung cancer ⬇️

artículo científico publicado el 25 de enero de 2011

Pemetrexed in the treatment of advanced non-squamous lung cancer

artículo científico publicado en 2009

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).

artículo científico publicado en 2018

Pharmacokinetics of Navelbine oral in elderly patients

artículo científico publicado en 2002

Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy

artículo científico publicado en 2015

Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step Trial ⬇️

artículo científico publicado el 1 de enero de 2012

Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly

artículo científico publicado en 2004

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

artículo científico publicado en 2017

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

artículo científico publicado en 2005

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

artículo científico publicado en 2012

Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer

artículo científico publicado en 2014

Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin

artículo científico publicado en 2003

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

artículo científico publicado en 2012

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

artículo científico publicado en 2013

Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer

artículo científico publicado en 2013

Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

artículo científico publicado en 2002

Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies

artículo científico publicado en 2017

Recent advances in targeted advanced lung cancer therapy in the elderly

artículo científico publicado en 2017

Recent developments of targeted therapies in the treatment of non-small cell lung cancer

scientific article published on June 2009

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

artículo científico publicado en 2009

Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies

artículo científico publicado en 2016

Review: Treating advanced non-small cell lung cancer in the elderly ⬇️

artículo científico publicado el 1 de julio de 2010

Risk-related F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial

article

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy

artículo científico publicado en 2016

Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel

artículo científico publicado en 2007

Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies

artículo científico publicado en 2017

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study

artículo científico publicado en 2015

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 tri

artículo científico publicado en 2015

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-cont

artículo científico publicado en 2015

Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases

artículo científico publicado en 2005

Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients

artículo científico publicado en 2005

Safety profiles of first-line therapies for metastatic non-squamous non-small-cell lung cancer

artículo científico publicado en 2016

Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

artículo científico publicado en 2012

Same old story? Do we need to modify our supportive care treatment of elderly cancer patients? Focus on antiemetics

artículo científico publicado en 2004

Screening for lung cancer: New horizons?

artículo científico publicado en 2005

Second and third line treatment in non-small cell lung cancer

artículo científico publicado en 2009

Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology

artículo científico publicado en 2017

Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized Trial

artículo científico publicado en 2016

Second-line treatment of advanced non-small cell lung cancer

artículo científico publicado en 2008

Selumetinib for the treatment of non-small cell lung cancer

artículo científico publicado en 2017

Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

artículo científico publicado en 2003

Single-agent chemotherapy for the treatment of elderly patients with advanced non-small-cell lung cancer: what is the best drug?

artículo científico publicado en 2007

Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial

artículo científico publicado en 2007

Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment

Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer

artículo científico publicado en 2007

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

artículo científico publicado en 2015

Synchronous bilateral retinal metastases from lung adenocarcinoma

artículo científico publicado en 2005

Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients

artículo científico publicado en 2013

Targeted therapies and non-small-cell lung cancer: new developments

artículo científico publicado en 2007

Targeted therapies development in the treatment of advanced nonsmall cell lung cancer

artículo científico publicado en 2011

Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors

artículo científico publicado en 2017

Targeted therapies in the treatment of non small cell lung cancer: reality and hopes

artículo científico publicado en 2004

Targeted therapy developments in the treatment of non-small cell lung cancer: a promising but long and winding road.

artículo científico publicado en 2008

Thalidomide in small-cell lung cancer: is it a tombstone?

artículo científico publicado en 2008

The Combination of New Immunotherapy and Radiotherapy: A N ew Potential Treatment for Locally Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2016

The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology

artículo científico publicado en 2016

The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients

artículo científico publicado en 2008

The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancer.

artículo científico publicado en 2013

The PARAMOUNT trial: a phase III randomized study of maintenance pemetrexed versus placebo immediately following induction first-line treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer

artículo científico publicado en 2013

The PI3k inhibitors: new hopes in the battle against advanced NSCLC.

artículo científico

The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer

artículo científico publicado en 2016

The c-Met inhibitors: a new class of drugs in the battle against advanced nonsmall-cell lung cancer

artículo científico

The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?

artículo científico publicado en 2008

The emerging role of histology in the choice of first-line treatment of advanced non-small cell lung cancer: implication in the clinical decision-making

scientific article published on January 2010

The potential role of bevacizumab in early stages and locally advanced non-small cell lung cancer

artículo científico publicado en 2009

The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer

artículo científico publicado en 2008

The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer

artículo científico publicado en 2010

The potential role of mTOR inhibitors in non-small cell lung cancer

artículo científico publicado en 2008

The potential role of pharmacogenomic and genomic in the adjuvant treatment of early stage non small cell lung cancer ⬇️

scientific article published on June 2008

The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?

artículo científico publicado en 2017

The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments

artículo científico publicado en 2007

The role of cetuximab and other epidermal growth factor receptor monoclonal antibodies in the treatment of advanced non-small cell lung cancer

artículo científico publicado en 2008

The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderly

artículo científico publicado en 2017

The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial

artículo científico publicado en 2009

The role of maintenance treatment in advanced non-small-cell lung cancer: reality or early second line?

artículo científico publicado en 2010

The role of pembrolizumab in the treatment of advanced non-small cell lung cancer

artículo científico publicado en 2016

The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial

artículo científico publicado en 2010

The role of targeted therapy in non-small cell lung cancer

artículo científico publicado en 2004

The safety of second-line treatment options for non-small cell lung cancer

artículo científico publicado en 2017

The use of bisphosphonates in elderly cancer patients

artículo científico publicado en 2007

Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancer.

artículo científico publicado en 2007

Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting

artículo científico publicado en 2011

Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

artículo científico

Treatment of advanced non small cell lung cancer ⬇️

artículo científico publicado el 1 de junio de 2011

Treatment of advanced non-small-cell lung cancer in the elderly

artículo científico publicado en 2009

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel

artículo científico publicado en 2005

Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines

artículo científico publicado en 2011

Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that's the question

artículo científico publicado en 2016

Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents

artículo científico publicado en 2003

Treatment of pulmonary neuroendocrine tumours: state of the art and future developments

artículo científico

Treatment of small-cell lung cancer in elderly patients

artículo científico publicado en 2010

Treatment of stage I-III non-small-cell lung cancer in the elderly

artículo científico publicado en 2006

Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

artículo científico publicado en 2005

Unanswered questions: monoclonal antibodies in the treatment of advanced non-small-cell lung cancer

artículo científico publicado el 30 de noviembre de 2010

Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen

artículo científico publicado en 2009

Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy

artículo científico publicado en 2009

Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer

artículo científico publicado en 2009

Vascular endothelial growth factor receptor as target for advanced non-small cell lung cancer therapy

artículo científico publicado en 2010

Vinorelbine in the treatment of non-small cell lung cancer

artículo científico publicado en 2002

Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study

artículo científico publicado en 2002

Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial

artículo científico publicado en 2008

What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO).

artículo científico publicado en 2016

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial.

artículo científico publicado en 2018

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda